Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Atlanta, Georgia
- Most recent report
- 8-K, filed Sep 29, 2026
- Incorporated
- Delaware
- Filings on record
- 397 filings
- On EDGAR
- CIK 1677077
- Fiscal year ends
- April
- Filer status
- Emerging growth company
Financials 8 of 22
News 8 of 71
- 8-K Current report on a material event Sep 29, 2026
- 8-K Significant contract Aug 3, 2026
- 8-K Other events Jul 21, 2026
- 8-K Shareholder vote results Apr 17, 2026
- 8-K Current report on a material event Mar 20, 2026
- 8-K Significant contract Mar 6, 2026
- 8-K Other events Nov 18, 2025
- 8-K Current report on a material event Oct 14, 2025
Prospectuses and Registrations 8 of 23
- S-1 Registration statement for an offering Aug 21, 2026
- 424B5 Prospectus supplement for an offering Mar 6, 2026
- 424B3 Prospectus supplement for an offering Apr 9, 2025
- S-1/A Registration statement for an offering, amended Mar 27, 2025
- S-3 Shelf registration statement Mar 13, 2025
- 424B5 Prospectus supplement for an offering Oct 3, 2024
- 424B3 Prospectus supplement for an offering Jul 10, 2024
- S-1/A Registration statement for an offering, amended Jul 3, 2024
Proxies 8 of 18
- PRE 14A Preliminary proxy statement Aug 28, 2026
- DEFA14A Extra proxy material Feb 26, 2026
- DEF 14A Proxy statement for a shareholder vote Feb 26, 2026
- PRE 14A Preliminary proxy statement Feb 9, 2026
- DEFA14A Extra proxy material Mar 19, 2025
- DEFA14A Extra proxy material Mar 17, 2025
- DEF 14A Proxy statement for a shareholder vote Mar 13, 2025
- PRE 14A Preliminary proxy statement Feb 28, 2025
Ownership 8 of 184
- 4 Insider reported a trade Aug 31, 2026
- 4/A Insider reported a trade, amended Aug 31, 2026
- 4/A Insider reported a trade, amended Aug 31, 2026
- 4/A Insider reported a trade, amended Aug 20, 2026
- 3/A Insider reported their initial holding, amended Aug 20, 2026
- 4 Insider reported a trade Aug 4, 2026
- 3 Insider reported their initial holding Aug 4, 2026
- 4 Insider reported a trade Aug 4, 2026
Other 8 of 79
- RW Oct 9, 2026
- EFFECT Notice that a registration became effective Apr 8, 2025
- CORRESP Reply to SEC staff Apr 4, 2025
- UPLOAD Comment letter from SEC staff Mar 21, 2025
- NT 10-K Notice that an annual report will be late Jul 30, 2024
- EFFECT Notice that a registration became effective Jul 9, 2024
- CORRESP Reply to SEC staff Jul 8, 2024
- CORRESP Reply to SEC staff Jul 3, 2024
Everything here comes from Alzamend Neuro, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.